Chen, Aiqi. 2025. “CD19 And CD22 Dual-Target CAR-T Therapy Via CRISPR Cas9 Engineering for Relapsed B-Cell Acute Lymphoblastic Leukemia”. Academic Journal of Science and Technology 18 (1): 621-25. https://doi.org/10.54097/79zwp242.